Hypoxia is a hallmark of respiratory, neurological or hematological diseases as well as life at high altitude. For example, chronic constant hypoxia (CCH) occurs in chronic lung diseases or at high altitude, whereas chronic intermittent hypoxia (CIH) occurs in diseases such as sleep apnea or sickle cell disease. In spite of the fact that such conditions are frequent, the cellular and molecular mechanisms underlying the effect of hypoxia, whether constant or intermittent, are not well understood. In this study, we first determined the effect of CCH and CIH on global gene expression in different regions of mouse brain using microarrays and then investigated the biological role of genes of interest. We found that: 1) in the cortical region, the expression level of 80 genes was significantly altered by and this number increased to 137 genes following CCH (34 up-and 103 down-regulated); 2) a similar number of gene alterations was identified in the hippocampal area, and the majority of the changes in this region were up-regulations; 3) two genes (Sspn and Ttc27) were downregulated in both brain regions and following both treatments; and 4) RNAi-mediated knockdown of Sspn increased cell death in hypoxia in a cell culture system. We conclude that CIH or CCH induced significant and distinguishable alterations in gene expression in cortex and hippocampus and that Sspn seems to play a critical role in inducing cell death under hypoxic conditions.
Introduction
It is well known that environmental factors that modulate normal growth conditions at an early postnatal age can have a long-lasting effect on brain function and structure. Oxygen deprivation can occur in many childhood diseases such as obstructive sleep apnea (OSA)(5), brochopulmonary dysplasia (BPD)(28), congenital heart disease (CHD), asthma, epilepsy and sickle cell disease (SCD). The affected infants often have long-lasting pathological outcomes accompanied with cognitive and/or behavioral disturbances (4, 11, 13, 19, 21, 29) . The molecular mechanisms underlying the effects of hypoxia on postnatal brain development are now still largely unknown.
In rodents, the rapid phase of cortical maturation and hippocampal development during the first few postnatal weeks corresponds to the first 2 to 3 postnatal years of rapid cortical and hippocampal development in humans (2) . Using the mouse model, previous studies in our laboratory and those of others have shown that O 2 deprivation can affect brain development in a major way. For example, an increase of capillary density, a decrease in myelination and a decrease of N-acetylaspartate to creatinine ratios (NAA/Cr) are some of the major findings (9, 12) . In order to further investigate the mechanisms underlying hypoxic injury or adaptation in the developing brain, we identified in this work the hypoxia-induced alterations in gene expression and biological networks in the neocortical and hippocampal regions following longterm postnatal hypoxic treatment. We chose these two important CNS regions because they are known to be vulnerable to hypoxia (20) . Two long-term hypoxia treatment paradigms were applied separately to mimic the hypoxic conditions that can take place in different environmental or health conditions. One paradigm is a chronic intermittent hypoxia (CIH) that mimics
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conditions such as OSA. The other paradigm is a chronic consistent hypoxia (CCH) that mimics conditions such as brochopulmonary dysplasia, sickle cell disease, and at high altitude.
Early postnatal brain development includes growth of axons, formation of specific synaptic connections and the fast proliferation of glial cells. Therefore, the postnatal development of the brain should no longer be considered solely as the development of neuronal network contacts, but also formation of the integrated circuitries of interactive neurons and glial cells. Indeed, it has been shown that chronic neonatal hypoxia led to decrease of volume and cell number in the cerebral cortex, especially a reduction of glial cells in white matter (3, 25) . A better understanding of glial cell biology, especially their responses to chronic hypoxia, can offer potential hints for developing novel therapeutic strategies to treat hypoxia-induced neurological disorders. In the current study, we determined the gene expression profiles in the neocortex and hippocampus of developing mouse brain following CCH or CIH treatments. We found that the expression of sarcospan (Sspn) gene was significantly down-regulated in both brain regions following either CCH or CIH treatment. The role of Sspn in cell survival under hypoxia was further determined in cultured glioma cells.
Materials and Methods
Animals, hypoxia treatment and tissue preparation. CD-1 mice (Charles River, MA) were utilized for all experiments. This mouse strain has been extensively evaluated in our laboratory (9, 10, 12) . All litters were culled to 8 pups each. On the second day after birth (P2), litters and their mothers were placed in plexiglass chambers. In CCH experiments, 11% of O 2 concentration was applied continuously. In CIH experiments, O 2 concentration was changed in cycles between 21% for 4 min and 11% for another 4 min throughout 24 hours/day (10) . Control Page 4 of 35 litters were housed in identical chambers and exposed to room air. Animals were housed under 12-hour light/dark cycles with free access to food and water. After 2 weeks of treatment, the mice were decapitated after halothane anesthesia, and the brains were rapidly removed. Four brain regions (cortex, hippocampus, brain stem-diencephalon, and cerebellum) were quickly separated on ice, flash-frozen in liquid nitrogen, and stored at -80°C till use. All animals were treated in accordance with the guidelines provided by the Animal Care Committee of Albert Einstein College of Medicine of Yeshiva University, which is accredited by the American Association of Laboratory Animal Care.
Total RNA purification and cRNA labeling. Total RNA was extracted from frozen cortical and hippocampal tissues of three individual mice for each treatment (normoxia, CIH and CCH) using RNeasy kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. The RNA quality was determined by Agilent 2100 bioanalyzer (Agilent Technologies). Total RNA (300 ng) was used to create a biotin-labeled complimentary RNA (cRNA) by the Illumina RNA amplification kit (Ambion) according to the manufacturer's instructions.
Microarray hybridization, image acquisition and data analyses.
The Sentrix mouse-6 expression beadchips (Illumina, San Diego, CA) were used to determine differences in gene expression (14) . Each beadchip contains six whole-genome gene expression arrays, allowing six samples to be hybridized to a single chip and with > 47000 probes to query expression profiles of the mouse genome. Hybridizations were carried out by using the Illumina gene expression system according to the manufacturer's instructions. Briefly, biotin-labeled cRNA (1.5 µg) was added to the array and incubated for 16-20 hours at 55ºC. The bound biotin-labeled cRNA was then stained with streptavidin-Cy3. Three chips were processed. Each chip contains 6 individual arrays that can measure the gene expression levels of 6 individual samples. We processed a group of 6 samples with each chip that included 1 control-cortical sample; 1 CIH-cortical sample; 1 CCH-cortical sample; 1 control-hippocampal sample; CIH-hippocampal sample, and 1 CCH-hippocampal sample. Thus, 3 individual measurements were performed for each treatment in each brain region. After hybridization, the microarray chip was washed, dried, and scanned by the Illumina BeadArray Reader, the absolute intensity of each probe on the image was generated with BeadStudio software (Illumina, San Diego, CA KIF11 Stealth Select RNAi was used as positive control to assess transfection efficiency.
Cells in which KIF11 was knocked down arrested during mitosis, and exhibited a "rounded-up" morphology in adherent cells after 24 to 30 hours. We assessed transfection efficiency by determining the number of arrested cells (over 50%).
Semi-quantitative reverse transcriptase PCR (RT-PCR) assay.
Semi-quantitative RT-PCR was also used to confirm the mRNA levels of five selected genes identified by microarray as well as the level of Sspn mRNA following RNAi transfection. All specific primers were designed by the software Primer 3 (23) and synthesized at ValueGene (San Diego, CA) (Supplementary Table 2 ). The validation of the microarray results was done by determining the changes in the same total RNA samples used in the microarray experiments. Briefly, first strand cDNA was synthesized from 1 µg of total RNA using SuperScriptII reverse transcriptase and Oligo-(dT) primer in a 20 µl reaction volume according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). The cDNA (100 ng) was used for each PCR reaction. The number of PCR cycles used for each primer is shown in Table 1 Lactate dehydrogenase (LDH) assay. LDH activity in cells and supernatant was determined using a LDH assay kit (Sigma, St. Louis, MO) according to the manufacturer's instructions.
Briefly, the supernatant containing the released LDH from the damaged cells was removed into a microcentrifuge tube. The cells remaining in the plate were lyzed to release all intracellular LDH. The LDH released from the damaged cells and from the lyzed cells were separately subjected to the LDH assay. In brief, 100 µl of the mixture of LDH-assay substrate, cofactor and dye solution (1:1:1) was added to each 50 µl supernatant or 50 µl cell lysate, and the plate was incubated at room temperature for 30 min, followed by adding 15 µl of 1N HCl to each well.
The assay is based on the presence of released, cellular LDH in the culture media. Table 1 ). In contrast to the cortex, most of the significant changes in the hippocampal region were up-regulations. Out of all the altered transcripts, 22 transcripts responded to both CIH and CCH in the cortex (2 up-regulated and 19 down-regulated) ( Table 1 ).
In the hippocampal region, 11 transcripts were found to be significantly altered following both CIH and CCH, and most of them were up-regulated (Table 2) . Interestingly, there were more transcripts that were significantly altered following CCH, as compared to CIH. For example, following CIH, 26 transcripts were altered in both cortical and hippocampal regions (12 upregulated and 14 down-regulated, Table 3 ), whereas, following CCH, 37 transcripts changed their expression in both cortical and hippocampal regions (26 up-regulated and 11 downregulated, Table 4 ). Only two genes were found to be altered (i.e. down-regulated) in both brain regions following both treatments. One of them encodes sarcospan (Sspn) and the other one encodes for tetratricopeptide repeat domain 27 (Ttc27).
The data from the microarrays were evaluated using semi-quantitative RT-PCR. As presented in Figure 1 , the data from the microarrays and semi-quantitative Real-Time PCR were qualitatively similar.
Distinct gene expression following CIH or CCH.
The significantly altered genes were categorized based upon the magnitude of change. We found that: 1) most genes in the cortex were down-regulated following CIH (~80%) or CCH (~75%). Although the majority of these changes were less than two-fold following either CIH or CCH ( Figure 2B (Table 5, Supplementary Tables 3 to 6 ). In the cortical region, CIH induced alterations that were categorized into 3 distinct networks which regulate CNS function, cell death, and various neurological diseases or conditions. CCH induced alterations in 5 networks that regulate cell signaling, and CNS development and metabolism. On the other hand, in the hippocampal region, CIH induced alterations in the networks that regulate mainly inflammatory/immune responses and cell death. CCH, however, induced changes that are mainly related to cellular development and vascular growth/oxygen transport (Table 5) .
Sspn down-regulation induces cell death.
Sspn is a member of the tetraspan superfamily that has been implicated in cell signaling, such as cell adhesion, migration, and proliferation (15, 17, 30) .
Interestingly, also, Sspn seems to have a role in ROS generation and scavenging ( Figure 3 ). In the current study, Sspn is the only characterized gene that was found to be down-regulated in all conditions and brain regions, suggesting that Sspn plays an important role during O 2 deprivation
by affecting processes such as cell proliferation and survival. In order to test this hypothesis, we studied the effect of Sspn knockdown on cell proliferation or death in a cultured glioma cell line (LN-229) using BrdU incorporation or LDH release assays.
As shown in Figure Figure 4C ). A similar pattern was also detected in Sspn knockdown cells following 3 days of hypoxia (data not show).
Discussion
Diseases that occur during childhood, such as obstructive sleep apnea, brochopulmonary dysplasia, asthma, and sickle cell disease, can often have long-term pathological outcomes, accompanied with cognitive and/or behavioral disturbances. Since one of the important elements of these diseases or conditions is low oxygenation, we wished to study the effect of hypoxia on the central nervous system (CNS), especially on neocortex and hippocampus, because the disturbances and defects in these children suggested the involvement of these brain regions. To understand and dissect the mechanisms underlying the effects of chronic intermittent (CIH) or chronic consistent hypoxia (CCH) on cortical and hippocampal development, genome-wide gene expression profiles were evaluated in the neocortex and hippocampus. This is the first systematic investigation of the expressional response to long-term CCH or CIH in developing mouse brain in their first few weeks of life. The reason for choosing this exposure time (the first humans (2).
Both hypoxia paradigms, CIH and CCH, induced major changes in the developing mouse brain. Of interest, the gene expression response to hypoxia in the developing brain seems to be region-and hypoxia paradigm-specific. For example, the majority of changes was essentially a down-regulation in the neocortex (~80% following CIH and ~75% following CCH) but an upregulation in the hippocampus (~80% following CIH and 85% following CCH), demonstrating that hypoxia induced more suppression on gene expression in the neocortex, but more of an activation in gene expression in the hippocampus. Such dramatic differences demonstrated also that distinct transcriptional regulatory mechanisms were involved in a tissue/cell specific manner to cope with oxygen deprivation in the brain. Furthermore, pathway analysis showed that CIH and CCH induced different alterations in functional networks. For instance, although CIH and CCH both induced an up-regulation of many genes in the hippocampus, the alterations induced by CIH were mainly in the networks that regulate inflammatory and immune responses that might lead to a variety of neurological diseases. In contrast, the alterations induced by CCH were mainly in the networks that contribute to oxygen transport and cellular rearrangement that might lead to an adaptation in the brain (Table 5) . These results suggest different impacts of CIH and CCH on the brain. It seems that CCH induced more of an "adaptive response" whereas CIH induced more of a pathological one. Indeed, CCH, but not CIH, induced a coordinated upregulation of aminolevulinic acid synthase 2 (erythroid, Alas2) and globins in both cortical and hippocampal regions, which demonstrated a synchronized up-regulation of heme and globin production and hence an increase in oxygen transport capacity that can cope with oxygen deprivation in the brain. On the other hand, glyoxalase 1 (Glo1) was down-regulated in both hippocampus and cortex following CIH. As glyoxalase system plays an important role in methylglyoxal detoxification that reduces the possible occurrence of oxidative stress in cells (1, 8, 22) , down-regulation of this enzyme might enhance the cytotoxicity of methylglyoxal, therefore, causes CNS injury in the developing brain following CIH treatment. In addition, in the current study, most of the altered genes were for the first time related to hypoxia-induced functional disturbances in the brain. For example, 14 significantly altered genes were categorized into a network that contributes to neurological diseases and psychological disorders in the cortex following CIH treatment (Table 5 ). According to PubMed search, 10 of them were related to hypoxia responses for the first time in the current study.
The down-regulation of Sspn in our work induced significant cell death without a profound effect on cell proliferation in a glioma cell culture ( Figure 4B 
